dementia 痴呆 jie ming shen, m.d., ph.d. department of neurology ruijin hospital, ssmu

30
Dementia 痴痴 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Upload: nicholas-cummings

Post on 04-Jan-2016

252 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Dementia

痴呆Jie Ming Shen, M.D., Ph.D.

Department of Neurology

Ruijin Hospital, SSMU

Page 2: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Defenition• A syndrome of acquired cognitive

and behavioral impairment to markedly interfere with social and occupational functioning.

Page 3: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Manifestation

• Memory• Language

• Visuospatial skills• Cognition

• Behavior & psychiatric syndrome• Eexecutive functionsxecutive functions

Page 4: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Types

Degeneration:• Alzheimer disease• Frontotemporal dementia & Pick’s diseas

e• Dementia with Lewy body

Non-Degeneration:• Vascular dementia

Page 5: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Alzheimer Disease

阿尔茨海默病

Page 6: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

定义• A progressive degeneration with unknown pathogenesis

• memory, cognitive and behavioral impairment

• cortic atrophy• lose of neurons

Page 7: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

pathogenesis

• Cause: unknown• hereditary• environment• metabolic abnormality• β- amyloid deposition in the brain • decrease in acetylcholine • other

Page 8: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Pathogenesis

• neurotoxic properties • formation of NFTs and SPs

Page 9: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Pathogenesis

Gene mutation• amyloid precursor protein (APP, on chromosome 21),

• presenilin I (on chromosome 14)• presenilin II (on chromosome 1)• lipoprotein E-epsilon 4 genotype

Page 10: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Pathology

cerebrocortical atrophy• temporal lobe• front lobe• parietal lobe

Page 11: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Pathology

•senile plaques (SPs)•neurofibrillary tangles•lose of neurons•granulovacular degeneration•cerebral amyloid angiopathy

Page 12: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Pathology

•neurofibrillary tanglesmicrotubule-associated protein tau-hyperphosphorylated.

Page 13: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Pathology

•lose of neurons• granulovacular degeneration•cerebral amyloid angiopathy

Page 14: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

•M=F•>65 y-o 5%•>85 y-o 20%•sporadic 90%

•familial history 5%

Page 15: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

Abnornalities in• ability of daily living• behaviour• cognition• mismanagement of funds or serious lapses in their family, social, and occupational responsibilities

Page 16: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

Early stage• slowly progressive memory loss of insidious onset in a fully consciousness, trouble remembering recent events or activities

• orientation disturbance• language disorders with communication

Page 17: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

Early stage• inability to solve simple arithmetic problems

• impairment in their visuospatial skills

Page 18: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

Early stage• problems with activities of daily living

• frontal gait• walk away from home and get lost • difficulty recognizing familiar people or things

• Greater risk of falls and accidents• cognition

Page 19: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

Late• more serious symptoms• psychiatric syndromes• Loss of mobility• behaviour

Page 20: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Clinic

Late• epilepsy• extrapyramid sign• clonus• pyramid sign• fecal incontinence

Page 21: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

WORK-UP

Imaging Studies• CT & MRI:cerebrocortic atrophy Lab Studies:• CSF tau protein Aβ • cognic scales •gene detection:

APP, PS-1, ApoE4

Page 22: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Psychology assessment scale • MMSE• WAISRC• CDR• BBS• HIS

Page 23: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Diagnosis• Age: 40-90 y-o• clinic manifestation of dementia + psychology assessment scale

• progressive memory & mental disturbance

• cognition disturbance • no consciousness problem• excluding encephalopathy

Page 24: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Differential diagnosis

• Mild cognitive impairment • Depression• Vascular dementia• Frontotemporal dementia• Dementia with Lewy body

Page 25: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Vascular dementiathe second most common cause of dementia• Cause: atherosclerosis, lacular infarctions in subcortic, basal ganglia and thalamus

• related to high blood pressure, high cholesterol, heart disease, diabetes, and related conditions. Treating those conditions can slow the progress of vascular dementia

Page 26: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Treatment• cholinesterase inhibitors (ChEIs) & the avoidance of centrally acting anticholinergic medications

• psychotropic medications & behavioral interventions Risperidone

• neuroprotect agents• N-methyl-D-aspartate (NMDA) antagonists• anti-inflammatory agents• clioquinoline, an antibiotic

Page 27: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

TreatmentCentrally cholinesterase inhibitors (ChEIs)• tacrine• Aricept5 mg PO qn for 3-4 wk, the 10 mg PO qd

• Exelon1.5 mg PO bid for 1 mo, 3 mg PO bid for 1 mo, 4.5 mg PO for 1 mo, then 6 mg PO bid

• Galantamine4-12 mg PO bid bid

Page 28: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

ChEIs adverse effects• nausea• vomiting• diarrhea• dizziness.

Page 29: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Neuroprotective agents

• Free-radical scavengers:Vitamin E 1000 IU PO bid

• MAO-BI: selegillin• gingko biloba•duxil

Page 30: Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU

Patient education

•patient education• Both physical and mental activities are recommended

• cognitive retraining